Morgan Stanley’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.48M | Sell |
|
|||||
|
2025
Q1 | $8.25M | Sell |
|
|||||
|
2024
Q4 | $10.5M | Sell |
|
|||||
|
2024
Q3 | $6.8M | Sell |
|
|||||
|
2024
Q2 | $9.2M | Sell |
|
|||||
|
2024
Q1 | $14.8M | Sell |
|
|||||
|
2023
Q4 | $27.8M | Buy |
|
|||||
|
2023
Q3 | $11.5M | Buy |
|
|||||
|
2023
Q2 | $8.32M | Buy |
|
|||||
|
2023
Q1 | $1.53M | Buy |
|
|||||
|
2022
Q4 | $549K | Buy |
|
|||||
|
2022
Q3 | $367K | Sell |
|
|||||
|
2022
Q2 | $823K | Sell |
|
|||||
|
2022
Q1 | $1.29M | Buy |
|
|||||
|
2021
Q4 | $922K | Buy |
|
|||||
|
2021
Q3 | $901K | Sell |
|
|||||
|
2021
Q2 | $2.59M | Buy |
|
|||||
|
2021
Q1 | $724K | Buy |
|
|||||
|
2020
Q4 | $549K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $3.12M | Buy |
|
|||||
|
2018
Q2 | $2.05M | Sell |
|
|||||
|
2018
Q1 | $2.75M | Sell |
|
|||||
|
2017
Q4 | $29.5M | Buy |
|
|||||
|
2017
Q3 | $18.3M | Buy |
|
|||||
|
2017
Q2 | $6.07M | Buy |
|
|||||
|
2017
Q1 | $3.64M | Sell |
|
|||||
|
2016
Q4 | $4.09M | Buy |
|
|||||
|
2016
Q3 | $1.69M | Sell |
|
|||||
|
2016
Q2 | $2.7M | Sell |
|
|||||
|
2016
Q1 | $3.96M | Buy |
|
|||||
|
2015
Q4 | $1.76M | Sell |
|
|||||
|
2015
Q3 | $2.09M | Buy |
|
|||||
|
2015
Q2 | $2.23M | Buy |
|
|||||
|
2015
Q1 | $1.79M | Sell |
|
|||||
|
2014
Q4 | $2.52M | Buy |
|
|||||
|
2014
Q3 | $1.26M | Buy |
|
|||||
|
2014
Q2 | $1.14M | Sell |
|
|||||
|
2014
Q1 | $1.03M | Buy |
|
|||||
|
2013
Q4 | $1.42M | Buy |
|
|||||
|
2013
Q3 | $122K | Buy |
|